Skip to content

Sana Biotechnology SANA Short- term Investments

Short- term Investments at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
Gilead Sciences logo
Gilead SciencesGILD
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
Beam Therapeutics logo
Beam TherapeuticsBEAM
Vor Biopharma logo
Vor BiopharmaVOR

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$907.23M+54.1%
Enterprise value$898.76M+53.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's short- term investments?
Sana Biotechnology (SANA) reported short- term investments of $17.34M in Q1 2026.
How has Sana Biotechnology's short- term investments changed year-over-year?
Sana Biotechnology's short- term investments increased by 102.3% year-over-year, from $8.57M to $17.34M.
What is the long-term trend for Sana Biotechnology's short- term investments?
Over 5 years (2020 to 2025), Sana Biotechnology's short- term investments has grown at a -23.5% compound annual growth rate (CAGR), from $253.46M to $66.51M.